4.8 Article

Common 5p15.33 and 6p21.33 variants influence lung cancer risk

期刊

NATURE GENETICS
卷 40, 期 12, 页码 1407-1409

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ng.273

关键词

-

资金

  1. Cancer Research UK [A1298/A8780]
  2. HEAL
  3. Sanofi-Aventis
  4. US NIH [P50CA70907, R01CA121197, R01CA133996]
  5. MRC [G0000934] Funding Source: UKRI
  6. Medical Research Council [G0000934] Funding Source: researchfish
  7. NATIONAL CANCER INSTITUTE [R01CA121197, P50CA070907, R01CA133996] Funding Source: NIH RePORTER

向作者/读者索取更多资源

We conducted a genome-wide association (GWA) study of lung cancer comparing 511,919 SNP genotypes in 1,952 cases and 1,438 controls. The most significant association was attained at 15q25.1 (rs8042374; P = 7.75 x 10(-12)), confirming recent observations. Pooling data with two other GWA studies (5,095 cases, 5,200 controls) and with replication in an additional 2,484 cases and 3,036 controls, we identified two newly associated risk loci mapping to 6p21.33 (rs3117582, BAT3-MSH5; P-combined 4.97 x 10(-10)) and 5p15.33 (rs401681, CLPTM1L; P-combined 7.90 x 10(-9)).

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据